Cargando…

Diagnosis and features of hospital-acquired pneumonia: a retrospective cohort study

BACKGROUND: Hospital-acquired pneumonia (HAP) is defined as radiologically confirmed pneumonia occurring ≥48 h after hospitalization, in non-intubated patients. Empirical treatment regimens use broad-spectrum antimicrobials. AIM: To evaluate the accuracy of the diagnosis of HAP and to describe the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Russell, C.D., Koch, O., Laurenson, I.F., O'Shea, D.T., Sutherland, R., Mackintosh, C.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172606/
https://www.ncbi.nlm.nih.gov/pubmed/26810613
http://dx.doi.org/10.1016/j.jhin.2015.11.013
_version_ 1783524286946869248
author Russell, C.D.
Koch, O.
Laurenson, I.F.
O'Shea, D.T.
Sutherland, R.
Mackintosh, C.L.
author_facet Russell, C.D.
Koch, O.
Laurenson, I.F.
O'Shea, D.T.
Sutherland, R.
Mackintosh, C.L.
author_sort Russell, C.D.
collection PubMed
description BACKGROUND: Hospital-acquired pneumonia (HAP) is defined as radiologically confirmed pneumonia occurring ≥48 h after hospitalization, in non-intubated patients. Empirical treatment regimens use broad-spectrum antimicrobials. AIM: To evaluate the accuracy of the diagnosis of HAP and to describe the demographic and microbiological features of patients with HAP. METHODS: Medical and surgical inpatients receiving intravenous antimicrobials for a clinical diagnosis of HAP at a UK tertiary care hospital between April 2013 and 2014 were identified. Demographic and clinical details were recorded. FINDINGS: A total of 166 adult patients with a clinical diagnosis of HAP were identified. Broad-spectrum antimicrobials were prescribed, primarily piperacillin–tazobactam (57.2%) and co-amoxiclav (12.5%). Sputum from 24.7% of patients was obtained for culture. Sixty-five percent of patients had radiological evidence of new/progressive infiltrate at the time of HAP treatment, therefore meeting HAP diagnostic criteria (2005 American Thoracic Society/Infectious Diseases Society of America guidelines). Radiologically confirmed HAP was associated with higher levels of inflammatory markers and sputum culture positivity. Previous surgery and/or endotracheal intubation were associated with radiologically confirmed HAP. A bacterial pathogen was identified from 17/35 sputum samples from radiologically confirmed HAP patients. These were Gram-negative bacilli (N = 11) or Staphylococcus aureus (N = 6). Gram-negative bacteria tended to be resistant to co-amoxiclav, but susceptible to ciprofloxacin, piperacillin–tazobactam and meropenem. Five of the six S. aureus isolates were meticillin susceptible and all were susceptible to doxycycline. CONCLUSION: In ward-level hospital practice ‘HAP’ is an over-used diagnosis that may be inaccurate in 35% of cases when objective radiological criteria are applied. Radiologically confirmed HAP represents a distinct clinical and microbiological phenotype. Potential risk factors were identified that could represent targets for preventive interventions.
format Online
Article
Text
id pubmed-7172606
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher The Authors. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71726062020-04-22 Diagnosis and features of hospital-acquired pneumonia: a retrospective cohort study Russell, C.D. Koch, O. Laurenson, I.F. O'Shea, D.T. Sutherland, R. Mackintosh, C.L. J Hosp Infect Article BACKGROUND: Hospital-acquired pneumonia (HAP) is defined as radiologically confirmed pneumonia occurring ≥48 h after hospitalization, in non-intubated patients. Empirical treatment regimens use broad-spectrum antimicrobials. AIM: To evaluate the accuracy of the diagnosis of HAP and to describe the demographic and microbiological features of patients with HAP. METHODS: Medical and surgical inpatients receiving intravenous antimicrobials for a clinical diagnosis of HAP at a UK tertiary care hospital between April 2013 and 2014 were identified. Demographic and clinical details were recorded. FINDINGS: A total of 166 adult patients with a clinical diagnosis of HAP were identified. Broad-spectrum antimicrobials were prescribed, primarily piperacillin–tazobactam (57.2%) and co-amoxiclav (12.5%). Sputum from 24.7% of patients was obtained for culture. Sixty-five percent of patients had radiological evidence of new/progressive infiltrate at the time of HAP treatment, therefore meeting HAP diagnostic criteria (2005 American Thoracic Society/Infectious Diseases Society of America guidelines). Radiologically confirmed HAP was associated with higher levels of inflammatory markers and sputum culture positivity. Previous surgery and/or endotracheal intubation were associated with radiologically confirmed HAP. A bacterial pathogen was identified from 17/35 sputum samples from radiologically confirmed HAP patients. These were Gram-negative bacilli (N = 11) or Staphylococcus aureus (N = 6). Gram-negative bacteria tended to be resistant to co-amoxiclav, but susceptible to ciprofloxacin, piperacillin–tazobactam and meropenem. Five of the six S. aureus isolates were meticillin susceptible and all were susceptible to doxycycline. CONCLUSION: In ward-level hospital practice ‘HAP’ is an over-used diagnosis that may be inaccurate in 35% of cases when objective radiological criteria are applied. Radiologically confirmed HAP represents a distinct clinical and microbiological phenotype. Potential risk factors were identified that could represent targets for preventive interventions. The Authors. Published by Elsevier Ltd. 2016-03 2015-12-15 /pmc/articles/PMC7172606/ /pubmed/26810613 http://dx.doi.org/10.1016/j.jhin.2015.11.013 Text en © 2015 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Russell, C.D.
Koch, O.
Laurenson, I.F.
O'Shea, D.T.
Sutherland, R.
Mackintosh, C.L.
Diagnosis and features of hospital-acquired pneumonia: a retrospective cohort study
title Diagnosis and features of hospital-acquired pneumonia: a retrospective cohort study
title_full Diagnosis and features of hospital-acquired pneumonia: a retrospective cohort study
title_fullStr Diagnosis and features of hospital-acquired pneumonia: a retrospective cohort study
title_full_unstemmed Diagnosis and features of hospital-acquired pneumonia: a retrospective cohort study
title_short Diagnosis and features of hospital-acquired pneumonia: a retrospective cohort study
title_sort diagnosis and features of hospital-acquired pneumonia: a retrospective cohort study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172606/
https://www.ncbi.nlm.nih.gov/pubmed/26810613
http://dx.doi.org/10.1016/j.jhin.2015.11.013
work_keys_str_mv AT russellcd diagnosisandfeaturesofhospitalacquiredpneumoniaaretrospectivecohortstudy
AT kocho diagnosisandfeaturesofhospitalacquiredpneumoniaaretrospectivecohortstudy
AT laurensonif diagnosisandfeaturesofhospitalacquiredpneumoniaaretrospectivecohortstudy
AT osheadt diagnosisandfeaturesofhospitalacquiredpneumoniaaretrospectivecohortstudy
AT sutherlandr diagnosisandfeaturesofhospitalacquiredpneumoniaaretrospectivecohortstudy
AT mackintoshcl diagnosisandfeaturesofhospitalacquiredpneumoniaaretrospectivecohortstudy